Three year results of the prostatic urethral L.I.F.T. study
Claus G. Roehrborn1, Daniel B. Rukstalis2, Jack Barkin3,
Steven N. Gange4, Neal D. Shore5, Jonathan L. Giddens6,
Damien M. Bolton7, Barrett E. Cowan8, Anthony L. Cantwell9,
Kevin T. McVary10, Alexis E. Te11, Shahram S. Gholami12,
William G. Moseley13, Peter T. Chin14, William T. Dowling15,
Sheldon J. Freedman16, Peter F. Incze17, K. Scott Coffield18,
Fernando D. Borges19, Prem Rashid20
Canadian Journal of Urology, Vol.22, No.3, pp. 7772-7782, 2015
Abstract Introduction: To report the three year results of a multi-center, randomized, patient and outcome assessor blinded trial of the Prostatic Urethral Lift (PUL) in men with bothersome lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH).
Materials and methods: At 19 centers in North America and Australia, 206 subjects ≥50 years old with International Prostate Symptom Score (IPSS) ≥13, peak flow rate (Qmax) ≤12 mL/s, and prostate volume between 30cc-80cc were randomized 2:1 to the PUL procedure or sham control. PUL involved placing permanent UroLift implants into the lateral lobes of the prostate to… More >